Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 4 of 4
Full-Text Articles in Medicine and Health Sciences
Patient Education On The Shingrix Vaccine, Arjun Patel
Patient Education On The Shingrix Vaccine, Arjun Patel
Family Medicine Clerkship Student Projects
The CDC recommends that most adults over the age of 50 get the Shingrix vaccine for protection against shingles (herpes zoster). Many patients at the WCHN Southbury Primary Care clinic in Connecticut are eligible for vaccination but are unaware of this newer vaccine or are unsure if they need the vaccine based on their past medical history and vaccination history. A brief, easy to understand handout was made to educate patients on the Shingrix vaccine and address frequently asked questions.
Shingrix: Educating Patients On The New Shingles Vaccine, Sarah Natasha Jost
Shingrix: Educating Patients On The New Shingles Vaccine, Sarah Natasha Jost
Family Medicine Clerkship Student Projects
Herpes zoster (shingles) is a viral infection that results in a painful rash and has a myriad of long-term complications, including post-herpetic neuralgia- chronic pain that does not resolved despite resolution of the rash. Over the last 20 years, incidence of shingles has increased by nearly 50% and now there are 2 vaccines available to prevent shingles. Shingrix was approved by the FDA in 2017 and has garnered public attention for its efficacy. I developed a brochure that gives patients information about shingles, Shingrix, and answers some frequently asked questions.
Shingles & Pneumococcal Vaccines: Recommendations For Older Adults, Benjamin Flinn
Shingles & Pneumococcal Vaccines: Recommendations For Older Adults, Benjamin Flinn
Family Medicine Clerkship Student Projects
As the immune system tends to weaken over time, patients aged 50+ begin having increased risk for certain potentially preventable diseases, especially shingles and pneumonia. Although there are vaccinations to protect against these diseases, there are many significant barriers preventing patients from receiving the vaccines that they need, including potentially confusing guidelines, concerns over risks, and recent changes to vaccine recommendations. This project aims to produce a clear and concise educational brochure to help overcome some of these barriers, and to drive patient-provider conversation about their vaccine recommendations.
The Shingrix Vaccine: Information For Patients About Current Recommendations & The National Shortage, Purvi Shah
The Shingrix Vaccine: Information For Patients About Current Recommendations & The National Shortage, Purvi Shah
Family Medicine Clerkship Student Projects
In the US, herpes zoster and related complications have been estimated to result in 1.3 billion dollars of medical costs alone annually. In order to combat this significant public health burden, efforts have been made to vaccinate susceptible populations for herpes zoster. In 2017, the FDA approved Shingrix, a recombinant zoster vaccine that is more effective than its predecessor, Zostavax. Now, patients are being vaccinated for shingles at a higher rate than previous years. As a result, the demand for Shingrix has exceeded supply, leading to an inconsistency in supply. This, in combination with changing recommendations for vaccination has generated …